Scoggin »

Lenz Therapeutics shares owned by Scoggin

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by Scoggin from 13F filings

Historical chart of Scoggin investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by Scoggin consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by Scoggin

Quarter filed Position value Share count Share price at filing
2025-09-30 $11M 225k 46.58
2025-06-30 $5.9M 200k 29.31
2025-03-31 $2.6M 100k 25.71

More positions owned by Scoggin

Terawulf (WULF)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Echostar Corp Cl A (SATS)
Core Scientific (CORZ)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Nebius Group Shs Class A (NBIS)
Ishares Bitcoin Trust Etf Shs Ben Int Put Option (IBIT)
Telephone & Data Sys Com New (TDS)
Energy Vault Holdings (NRGV)
Sable Offshore Corp Com Shs (SOC)
Advisorshares Tr Pure Us Cannabis (MSOS)
Lenz Therapeutics (LENZ)
Echostar Corp Note 3.875%11/3 (Principal)
Kenvue (KVUE)
Grayscale Ethereum Trust Etf SHS (ETHE)

View all positions for Scoggin

Top funds holding Lenz Therapeutics

RA Capital Management
Falcon Edge Capital
Versant Venture Management
BlackRock
Vanguard Group
UBS Group
Paradigm Biocapital Advisors
72 Investment Holdings
Tang Capital Management
Rtw Investments
First Light Asset Management
Adage Capital Partners GP
Franklin Resources
Morgan Stanley
Geode Capital Management

View all funds holding Lenz Therapeutics